Risk score | Time period | 10-year CVD risk as predicted by risk score (%) | No prior statin use n patients (%) | Prior statin use n patients (%) |
---|---|---|---|---|
Framingham risk score | <2007 | <5 | 794744 (99.5) | 3898 (0.5) |
5–10 | 519859 (98.1) | 10300 (1.9) | ||
10–15 | 329159 (96.2) | 12940 (3.8) | ||
15–20 | 202504 (94.6) | 11447 (5.4) | ||
≥20 | 319089 (92.8) | 24757 (7.2) | ||
≥2007 | <5 | 733476 (98.6) | 10686 (1.4) | |
5–10 | 368689 (94.1) | 22936 (5.9) | ||
10–15 | 181755 (87.9) | 24977 (12.1) | ||
15–20 | 89542 (80.8) | 21296 (19.2) | ||
≥20 | 88469 (70.3) | 37454 (29.7) | ||
ASSIGN risk score | <2007 | <5 | 909040 (99.4) | 5146 (0.6) |
5–10 | 539327 (97.7) | 12974 (2.3) | ||
10–15 | 266315 (95.3) | 13101 (4.7) | ||
15–20 | 173180 (94.1) | 10860 (5.9) | ||
≥20 | 277493 (92.9) | 21260 (7.1) | ||
≥2007 | <5 | 820316 (98.4) | 13377 (1.6) | |
5–10 | 370639 (93.0) | 27994 (7.0) | ||
10–15 | 145305 (84.4) | 26787 (15.6) | ||
15–20 | 68952 (76.7) | 20999 (23.3) | ||
≥20 | 56720 (66.8) | 28191 (33.2) | ||
QRISK2 risk score | <2007 | <5 | 1149295 (99.2) | 9128 (0.8) |
5–10 | 354037 (96.7) | 11927 (3.3) | ||
10–15 | 212654 (94.9) | 11453 (5.1) | ||
15–20 | 172081 (94.5) | 10014 (5.5) | ||
≥20 | 277287 (93.0) | 20818 (7.0) | ||
≥2007 | <5 | 969202 (98.0) | 19526 (2.0) | |
5–10 | 230873 (90.7) | 23748 (9.3) | ||
10–15 | 117838 (83.9) | 22529 (16.1) | ||
15–20 | 70006 (78.5) | 19172 (21.5) | ||
≥20 | 74014 (69.6) | 32374 (30.4) | ||
Any of the three risk scores (highest estimate) | <2007 | <5 | 760603 (99.6) | 3136 (0.4) |
5–10 | 486724 (98.3) | 8582 (1.7) | ||
10–15 | 299741 (96.4) | 11165 (3.6) | ||
15–20 | 216194 (95.1) | 11231 (4.9) | ||
≥20 | 402093 (93.2) | 29228 (6.8) | ||
≥2007 | <5 | 701025 (98.8) | 8450 (1.2) | |
5–10 | 354980 (94.9) | 18949 (5.1) | ||
10–15 | 183877 (89.1) | 22419 (10.9) | ||
15–20 | 103799 (82.8) | 21592 (17.2) | ||
≥20 | 118251 (72.0) | 45939 (28.0) |
GP, general practitioner.